glp 1 agonist action Mechanisms of of GLP-1RA Frontiers | GLP−1 receptor agonists
Description
By stimulating insulin secretion and reducing glucagon release, GLP-1 RAs lower blood sugar levels
NPJ Parkinsons Dis (2020) 6:15
41: e15379
As for clinical outcomes, in the T2DM group, there was a significant reduction in HbA1c (decreased by 1.01% to 1.02%, placebo-adjusted) and a clinically meaningful decrease in body weight of 3.26% to 3.51% after 12 weeks of treatment
